CRL · Full Picture

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — the full picture

Earnings window · 2026-07-15 to 2026-08-09 · anchored on the 10-Q report

One earnings window, everything merged: the filing, the call, press releases and news digests, folded into ranked threads.

What to look at first

  1. Income Tax Rate Changes · TaxPriority 77
    -9.2% net_income (realized); 2 sources (press_release, sec_filing); 1 forward row(s); structured_verified
    Provision for income taxes for the three months ended June 27, 2026: $53.93 million; income before income taxes: $53.17 million; effective tax rate: 101.4% compared to 26.2% in the prior-year period.
  2. Acquisitions and Divestitures · M&A and divestituresPriority 75
    +0.0% assets; 3 sources (news, press_release, sec_filing); 5 forward row(s); structured_verified
    Within Schedule 5, the gain (loss) on divestitures for three months ended June 27, 2026 primarily reflects a $63.7 million loss on the CDMO and Cell Solutions divestiture and a $0.3 million gain on the European Discovery Divestiture.
  3. Capital Return Program · Buybacks & dividendsPriority 75
    -8.2% cash (realized); 3 sources (news, press_release, sec_filing); structured_verified
    On October 29, 2025, the Board approved a stock repurchase program of $1.0 billion; during the six months ended June 27, 2026 Charles River repurchased 1.7 million shares for $300.0 million under the program, leaving $700.0 million remaining on the authorized program as of June 27, 2026.
  4. Liquidity and Debt Position · Debt, leverage & refinancingPriority 75
    -8.3% liability (realized); 2 sources (press_release, sec_filing); structured_verified
    As of June 27, 2026, $105.0 million of deferred consideration for the Cambodian NHP Supplier acquisition remains to be paid and is recorded in Accrued liabilities.
  5. Operating Margin Drivers · Operating income & profitabilityPriority 75
    +14.9% operating_income; 1 forward row(s); structured_verified
    Collective cost savings initiatives expected to generate approximately $300 million in cumulative, annualized cost savings by the end of 2026.
  6. End-Market Demand Trends · Demand, orders & backlogPriority 74
    +5.0% revenue; 3 sources (news, press_release, sec_filing); 1 forward row(s); structured_verified
    DSA backlog as of June 27, 2026: $2.0 billion, increased from $1.9 billion as of December 27, 2025.
  7. Headcount and Restructuring · Restructuring & impairmentPriority 67
    -7.7% operating_income (realized); structured_verified
    Restructuring charges were $99.8 million and $107.0 million during the fiscal years 2025 and 2024, respectively.
  8. Interest Rate and Refinancing Exposure · Interest ratesPriority 65
    quote_verified
    Interest expense for the six months ended June 27, 2026: $57,082 thousand, a decrease of $0.8 million or 1.3% compared to $57,851 thousand in the prior-year period, primarily due to lower average interest rates on revolving credit facility balances; partially offset by non-cash accretion related to the Cambodian acquisition.
  9. Operating Margin Drivers · UnclassifiedPriority 63
    +33.9% margin (realized); quote_verified
    Manufacturing GAAP operating margin in Q2 2026: 34.9% compared to 6.0% in Q2 2025, with non-GAAP operating margin of 37.8% versus 32.8% in Q2 2025, driven primarily by the CDMO business including the benefit from the divestiture.
  10. Operating Expense Trends · Operating expenses (SG&A)Priority 62
    -3.6% operating_income (realized); 2 sources (press_release, sec_filing); 4 forward row(s); quote_verified
    Unallocated corporate costs for the three months ended June 27, 2026: $106,394 thousand, an increase of $35,900 thousand or 50.9% compared to $70,494 thousand in the prior-year period.
  11. Revenue Performance and Mix · Revenue growth & mixPriority 59
    -5.4% net_income (realized); 3 sources (news, press_release, sec_filing); quote_verified
    Second-quarter revenue: $1.00 billion for the quarter ended June 27, 2026.
  12. Guidance / Outlook · Guidance & outlookPriority 54
    +1.0% revenue; 2 sources (news, press_release); 5 forward row(s); quote_verified
    New 2026 non-GAAP EPS estimate: $11.15 – $11.45 (prior $10.80 – $11.30).

Threads by pillar

Revenue & Demand Priority 85 · 5 threads

Costs & Margins Priority 86 · 4 threads

Capital & Balance Sheet Priority 90 · 5 threads

Strategy & Portfolio Priority 76 · 2 threads

Legal, Regulatory & Policy Priority 50 · 2 threads

Guidance & Outlook Priority 54 · 1 thread

Macro & Market Conditions Priority 72 · 3 threads

Unclassified Priority 68 · 4 threads

Expected impact by metric

metricforward netforward grossrealized
operating_income+14.6%+15.3%+13.3%
revenue+4.6%+10.3%-3.0%
assets+0.0%+0.0%-0.5%
liability-0.0%+0.0%-10.6%
cash——-7.6%
margin——+33.9%
net_income——-40.0%